SG11202000786RA - Prevention and/or treatment of neurodegenerative disease - Google Patents
Prevention and/or treatment of neurodegenerative diseaseInfo
- Publication number
- SG11202000786RA SG11202000786RA SG11202000786RA SG11202000786RA SG11202000786RA SG 11202000786R A SG11202000786R A SG 11202000786RA SG 11202000786R A SG11202000786R A SG 11202000786RA SG 11202000786R A SG11202000786R A SG 11202000786RA SG 11202000786R A SG11202000786R A SG 11202000786RA
- Authority
- SG
- Singapore
- Prior art keywords
- prevention
- treatment
- neurodegenerative disease
- neurodegenerative
- disease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Marine Sciences & Fisheries (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1720119.5A GB201720119D0 (en) | 2017-12-04 | 2017-12-04 | Prevention and/or treatment of neurodegenerative disease |
| PCT/GB2018/051255 WO2019110951A1 (en) | 2017-12-04 | 2018-05-10 | Prevention and/or treatment of neurodegenerative disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202000786RA true SG11202000786RA (en) | 2020-06-29 |
Family
ID=60950313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202000786RA SG11202000786RA (en) | 2017-12-04 | 2018-05-10 | Prevention and/or treatment of neurodegenerative disease |
Country Status (14)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3106957B1 (fr) * | 2020-02-07 | 2024-05-03 | Abdelhadi Zahouani | Composition alimentaire pour stimuler la fonction cognitive et prevenir et limiter le declin cognitif et la demence chez des sujets adultes ou chez des sujets ages denutris |
| US12076299B2 (en) * | 2020-02-20 | 2024-09-03 | Arjuna Natural Pvt Ltd | Composition and method to enhance cognitive support and brain health |
| TW202313075A (zh) * | 2021-05-17 | 2023-04-01 | 日商小野藥品工業股份有限公司 | 用於改善認知功能之組合物 |
| JPWO2024143060A1 (enrdf_load_stackoverflow) * | 2022-12-26 | 2024-07-04 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050163873A1 (en) | 2004-01-14 | 2005-07-28 | Robert Ritch | Methods and formulations for treating glaucoma |
| US8324276B2 (en) * | 2005-01-24 | 2012-12-04 | Pronova Biopharma Norge As | Fatty acid composition for treatment of alzheimer's disease and cognitive dysfunction |
| WO2006116755A2 (en) * | 2005-04-28 | 2006-11-02 | Trustees Of Tufts College | Synergitic effects of docosahexaenoic acid (dha) and carotenoid absorption of cognitive function |
| EP2219478B1 (en) * | 2007-12-17 | 2017-05-10 | Newtricious B.V. | Method of producing egg yolk based functional food product and products obtainable thereby |
| GB201014340D0 (en) | 2010-08-27 | 2010-10-13 | Piraee Mahmood | Nutritional supplement formulation comprising saffron and resveratrol |
| HUE038813T2 (hu) * | 2011-07-07 | 2018-11-28 | Howard Foundation Holdings Ltd | Eljárás rontó káprázás javítására |
| WO2014014766A1 (en) * | 2012-07-19 | 2014-01-23 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Krill oil and reacted astaxanthin composition and associated method |
| US20140187648A1 (en) * | 2013-01-03 | 2014-07-03 | Howard Foundation Holdings Ltd. | Identifying Subjects in Need of Treatment |
| GB201300055D0 (en) * | 2013-01-03 | 2013-02-20 | Howard Foundation Holdings Ltd | Identifying subjects in need of treatment |
| US9849096B2 (en) * | 2013-03-28 | 2017-12-26 | Omniactive Health Technologies Limited | Neuroprotective effect of carotenoids in brain |
| WO2015005443A1 (ja) * | 2013-07-10 | 2015-01-15 | ライオン株式会社 | 内服組成物 |
| JP6719574B2 (ja) * | 2016-02-22 | 2020-07-08 | ニュートリシャス ベー．フェー．Ｎｅｗｔｒｉｃｉｏｕｓ Ｂ．Ｖ． | 神経変性疾患の、予防または治療のための組成物 |
-
2017
- 2017-12-04 GB GBGB1720119.5A patent/GB201720119D0/en not_active Ceased
-
2018
- 2018-05-10 RU RU2020111305A patent/RU2020111305A/ru unknown
- 2018-05-10 EP EP25186112.6A patent/EP4599891A2/en active Pending
- 2018-05-10 BR BR112020005132-2A patent/BR112020005132A2/pt not_active Application Discontinuation
- 2018-05-10 AU AU2018379644A patent/AU2018379644B2/en active Active
- 2018-05-10 WO PCT/GB2018/051255 patent/WO2019110951A1/en active IP Right Grant
- 2018-05-10 EP EP18725605.2A patent/EP3644979B1/en active Active
- 2018-05-10 MX MX2020002458A patent/MX2020002458A/es unknown
- 2018-05-10 JP JP2020521460A patent/JP2021505527A/ja active Pending
- 2018-05-10 CA CA3071786A patent/CA3071786C/en active Active
- 2018-05-10 KR KR1020207007980A patent/KR20200095452A/ko active Pending
- 2018-05-10 GB GB1807590.3A patent/GB2568986B/en active Active
- 2018-05-10 SG SG11202000786RA patent/SG11202000786RA/en unknown
- 2018-05-15 IE IE20180146A patent/IE87241B1/en unknown
- 2018-05-15 US US15/980,083 patent/US10835509B2/en active Active
-
2020
- 2020-01-28 ZA ZA2020/00558A patent/ZA202000558B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB201807590D0 (en) | 2018-06-27 |
| GB2568986A (en) | 2019-06-05 |
| IE20180146A1 (en) | 2019-06-12 |
| EP3644979A1 (en) | 2020-05-06 |
| US20190167624A1 (en) | 2019-06-06 |
| KR20200095452A (ko) | 2020-08-10 |
| US10835509B2 (en) | 2020-11-17 |
| GB2568986B (en) | 2019-12-18 |
| RU2020111305A (ru) | 2022-01-10 |
| MX2020002458A (es) | 2020-07-20 |
| BR112020005132A2 (pt) | 2020-09-15 |
| WO2019110951A1 (en) | 2019-06-13 |
| NZ761512A (en) | 2024-01-26 |
| EP3644979B1 (en) | 2025-08-06 |
| AU2018379644A1 (en) | 2020-03-19 |
| CA3071786A1 (en) | 2019-06-13 |
| ZA202000558B (en) | 2021-10-27 |
| JP2021505527A (ja) | 2021-02-18 |
| EP4599891A2 (en) | 2025-08-13 |
| IE87241B1 (en) | 2021-07-07 |
| CA3071786C (en) | 2023-11-14 |
| GB201720119D0 (en) | 2018-01-17 |
| AU2018379644B2 (en) | 2024-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL277648A (en) | Medical microbiota for the treatment and/or prevention of food allergy | |
| ZA201908165B (en) | Compounds for the prevention and treatment of diseases and the use thereof | |
| ZA201901055B (en) | Treatment and prevention of sleep disorders | |
| ZA202000558B (en) | Prevention and/or treatment of neurodegenerative disease | |
| IL272097A (en) | Compounds for the prevention and treatment of medical disorders and their uses | |
| EP3694523A4 (en) | METHODS AND SUBSTANCES FOR PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES | |
| IL274588A (en) | Methods and preparations for improving lysosome function and treating neurodegenerative disease | |
| PL3558335T3 (pl) | Inhibicja kaspazy-1 i jej zastosowanie w zapobieganiu i leczeniu schorzeń neurologicznych | |
| GB201714307D0 (en) | Treatment of neurodegenerative diseases | |
| GB201616009D0 (en) | Treatment and/or prevention of sepsis | |
| RS65173B1 (sr) | Kompozicija za prevenciju i/ili lečenje simptoma alergije | |
| ZA201906964B (en) | Prevention and/or treatment of inflammatory skin disease | |
| EP3377062C0 (en) | AMINONAPHHOQUINONE COMPOUNDS FOR THE TREATMENT AND/OR PREVENTION OF FIBROSIS DISEASES | |
| GB201615298D0 (en) | Treatment and prevention of Malaria | |
| GB201522329D0 (en) | Use of adjuvants for the prevention and/or treatment of autoimmune diseases | |
| SG11201704430SA (en) | Preventive and/or therapeutic agent of immune disease | |
| SG11201705889VA (en) | Prevention or Treatment of Uratic or Gouty Diseases | |
| PL3137097T3 (pl) | Leczenie i profilaktyka choroby Alzheimera (AD) | |
| IL259383A (en) | A compound for use in the prevention and treatment of neurodegenerative diseases | |
| LT3137093T (lt) | Alzheimerio ligos (ad) gydymas ir prevencija | |
| PL3137094T3 (pl) | Leczenie i profilaktyka choroby alzheimera (ad) | |
| GB201719969D0 (en) | Prevention and/or treatment of neurodegenerative disease | |
| GB201714311D0 (en) | Treatment of neurodegenerative diseases | |
| GB201714303D0 (en) | Treatment of neurodegenerative diseases | |
| EP3490604C0 (en) | MEDICATION FOR THE TREATMENT AND/OR PREVENTION OF ENDOMETRIOSIS |